Annual report [Section 13 and 15(d), not S-K Item 405]

Fair Value Measurements and Hierarchy - Changes in Fair Value (Details)

v3.25.1
Fair Value Measurements and Hierarchy - Changes in Fair Value (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
May 24, 2024
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Beginning balance     $ 29  
Ending balance   $ 10,185 10,185 $ 29
Gain from change in fair value of warrant liability     (22,114) (433)
Medcore Health Plan, Inc and Omni IPA Medical Group, Inc        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Gain on write off of contingent consideration   $ (6,200) (6,200)  
Private Placement Warrants        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Beginning balance     29 40
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances $ 31,300   31,341 0
Mark-to-market adjustment of stock warrants     $ (21,185) (11)
Ending balance       $ 29
Private Placement Warrants | Level 3        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Expense Expense
Public Warrants        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation        
Gain from change in fair value of warrant liability     $ 22,100 $ 400